Prediction of metabolic clearance using fresh human hepatocytes: Comparison with cryopreserved hepatocytes and hepatic microsomes for five benzodiazepines

References

• Berry MN, Edwards AM, Barritt GJ. Isolated hepatocytes: preparation, properties and applications. Laboratory techniques in biochemistry and molecular biology, RH Burden, PH Knippenberg. Elsevier, New York, NY 1991; 46
   Google Scholar
• Binda D, Lasserre-Bigot D, Bonet A, Thomassin M, Come MP, Guinchard C, Bars R, Jacqueson A, Richert L. Time course of cytochromes P450 decline during rat hepatocyte isolation and culture: Effect of L-NAME. Toxicology in Vitro 2003; 17: 59–67
   PubMed Web of Science ®Google Scholar
• Brown HS, Griffin M, Houston JB. Evaluation of cryopreserved human hepatocytes as an alternative in vitro system to microsomes for the prediction of metabolic clearance. Drug Metabolism and Disposition 2007; 35: 293–301
   PubMed Web of Science ®Google Scholar
• Busby WF, Ackermann JR, Crespi CL. Effect of methanol, ethanol, dimethyl sulfoxide and acetonitrile on in vitro activities of CDNA-expressed human cytochromes P-450 Drug Metabolism. Disposition 1999; 27: 246–249
   Google Scholar
• Chen Q, Tan E, Strauss JR, Zhang Z, Fenyk-Melody JE, Booth-Genthe C, Rushmore TH, Stearns RA, Evans DC, Baillie TA, et al. Effect of quinidine on the 10-hydroxylation of R-warfarin: species differences and clearance projection. Journal of Pharmacology and Experimental Therapeutics 2004; 311: 307–314
   PubMedGoogle Scholar
• Egnell AC, Houston JB, Boyer S. In vivo CYP3A4 heteroactivation is a possible mechanism for the drug interaction between felbamate and carbamazepine Journal of Pharmacology and Experimental Therapeutics 2003; 305: 1251–1262
   Google Scholar
• Fisher RL, Gandolfi AJ, Brendel K. Human liver quality is a dominant factor in the outcome of in vitro studies. Cell Biology and Toxicology 2001; 17: 179–189
   PubMed Web of Science ®Google Scholar
• Griffin JE, Ojeda SR. Textbook of endocrine physiology4th. Oxford University Press, New York, NY 2000; 257
   Google Scholar
• Griffin SJ, Houston JB. Comparison of fresh and cryopreserved rat hepatocyte suspensions for the prediction of in vitro intrinsic clearance. Drug Metabolism and Disposition 2004; 32: 552–558
   PubMed Web of Science ®Google Scholar
• Grime K, Riley RJ. The impact of in vitro binding on in vitro–in vivo extrapolations, projections of metabolic clearance and clinical drug–drug interactions. Current Drug Metabolism 2006; 7: 251–264
   PubMed Web of Science ®Google Scholar
• Hallifax D, Rawden HC, Hazook N, Houston JB. Prediction of metabolic clearance using cryopreserved human hepatocytes: Kinetic characteristics for five benzodiazepines. Drug Metabolism and Disposition 2005; 33: 1852–1858
   PubMed Web of Science ®Google Scholar
• Hewitt NJ, Gomez Lechon MJ, Houston JB, Hallifax D, Brown HS, Maurel P, Kenna JG, Gustavsson L, Lohmann C, Skonberg C, et al. Primary hepatocytes: Current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies. Drug Metabolism Reviews 2007; 39: 159–234
   PubMed Web of Science ®Google Scholar
• Hickman D, Wang JP, Wang Y, Unadkat JD. Evaluation of the selectivity of in vitro probes and suitability of organic solvents for the measurement of human cytochrome P450 monooxygenase activity. Drug Metabolism and Disposition 1998; 26: 207–215
   PubMed Web of Science ®Google Scholar
• Houston JB. Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance. Biochemical Pharmacology 1994; 47: 1469–1479
   PubMed Web of Science ®Google Scholar
• Houston JB, Carlile DJ. Prediction of hepatic clearance from microsomes, hepatocytes and liver slices. Drug Metabolism Reviews 1997; 29: 891–922
   PubMed Web of Science ®Google Scholar
• Houston JB, Galetin A. Modelling atypical CYP3A4 kinetics: Principles and pragmatism. Archives of Biochemistry and Biophysics 2005; 433: 351–360
   PubMed Web of Science ®Google Scholar
• Houston JB, Kenworthy KE. In vitro–in vivo scaling of cytochrome P450 kinetic data not consistent with the classical Michaelis–Menten model. Drug Metabolism and Disposition 1999; 28: 246–254
   Google Scholar
• Ito K, Houston JB. Comparison of the use of liver models for prediction of drug clearance using in vitro kinetic data from hepatic microsomes and isolated hepatocytes. Pharmaceutical Research 2004; 21: 785–792
   PubMed Web of Science ®Google Scholar
• Ito K, Houston JB. Prediction of human drug clearance from in vitro and preclinical data using physiologically based and empirical approaches. Pharmaceutical Research 2005; 22: 103–112
   PubMed Web of Science ®Google Scholar
• Kenworthy KE, Clarke SE, Andrews J, Houston JB. Multisite kinetic models for CYP3A4: Simultaneous activation and inhibition of diazepam and testosterone metabolism. Drug Metabolism and Disposition 2001; 29: 1644–1651
   PubMed Web of Science ®Google Scholar
• Lau YY, Sapidou E, Cui X, White RE, Cheng KC. Development of a novel in vitro model to predict hepatic clearance using fresh, cryopreserved and sandwich-cultured hepatocytes. Drug Metabolism and Disposition 2002; 30: 1446–1454
   PubMed Web of Science ®Google Scholar
• Maenpaa J, Hall SD, Ring BJ, Strom SC. Human cytochrome P450 3A (CYP3A) mediated midazolam metabolism: The effect of assay conditions and regioselective stimulation by α-naphthoflavone, terfenadine and testosterone. Pharmacogenetics 1998; 8: 137–155
   PubMedGoogle Scholar
• McGinnity DF, Soars MG, Urbanowicz RA, Riley RJ. Evaluation of fresh and cryopreserved hepatocytes as in vitro drug metabolism tools for the prediction of metabolic clearance. Drug Metabolism and Disposition 2004; 32: 1247–1253
   PubMed Web of Science ®Google Scholar
• Nakamura H, Nakasa H, Ishii I, Ariyoshi N, Igarashi T, Ohmori S, Kitada M. Effects of endogenous steroids on CYP3A4-mediated drug metabolism by human liver microsomes. Drug Metabolism and Disposition 2002; 30: 534–540
   PubMed Web of Science ®Google Scholar
• Naritomi Y, Terashita S, Kagayama A, Sugiyama Y. Utility of hepatocytes in predicting drug metabolism: Comparison of hepatic intrinsic clearance in rats and humans in vivo and in vitro. Drug Metabolism and Disposition 2003; 31: 580–588
   PubMed Web of Science ®Google Scholar
• Ngui JS, Chen Q, Shou M, Wang RW, Stearns RA, Baillie T, Tang W. In vitro stimulation of warfarin metabolism by quinidine: increases in the formation of 4′-hydroxylation and 10-hydroxywarfarin. Drug Metabolism and Disposition 2001; 29: 877–886
   PubMed Web of Science ®Google Scholar
• Ngui JS, Tang W, Stearns RW, Shou M, Miller RR, Zhang Y, Lin JH, Baillie T. Cytochrome P450 3A4-mediated interaction of diclofenac and quinidine. Drug Metabolism and Disposition 2000; 28: 1043–1050
   PubMed Web of Science ®Google Scholar
• Patki KC, Von Moltke LL, Greenblatt DJ. In vitro metabolism of midazolam, triazolam, nifedipine and testosterone by human liver microsomes and recombinant cytochromes P450: role of CYP3A4 and CYP3A5. Drug Metabolism and Disposition 2003; 31: 938–944
   PubMed Web of Science ®Google Scholar
• Rawden HC, Carlile DJ, Tindall A, Hallifax D, Galetin A, Ito K, Houston JB. Microsomal prediction of in vivo clearance and associated inter-individual variability of six benzodiazepines in humans. Xenobiotica 2005; 35: 603–625
   PubMed Web of Science ®Google Scholar
• Rawden HC, Tindall A, Hallifax D, Houston JB. Heteroactivation of CYP3A4 substrates: Impact on intrinsic clearance and inter-individual variability. Drug Metabolism Reviews 2001; 33: 211
   Google Scholar
• Riley RJ, McGinnity DF, Austin RP. A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes. Drug Metabolism and Disposition 2005; 33: 1304–1311
   PubMed Web of Science ®Google Scholar
• Schrag ML, Weinkers LC. Triazolam substrate inhibition: evidence of competition for heme-bound reactive oxygen within the CYP3A4 active site. Drug Metabolism and Disposition 2001; 29: 70–75
   PubMed Web of Science ®Google Scholar
• Shibata Y, Takahashi H, Chiba M, Ishii Y. Prediction of hepatic clearance and availability by cryopreserved human hepatocytes: An application of the serum incubation method. Drug Metabolism and Disposition 2002; 30: 892–896
   PubMed Web of Science ®Google Scholar
• Soars MG, Burchell B, Riley RJ. In vitro analysis of human drug glucuronidation and prediction of in vivo metabolic clearance. Journal of Pharmacology and Experimental Therapeutics 2002; 301: 382–390
   PubMed Web of Science ®Google Scholar
• Soars MG, McGinnity DF, Grime K, Riley RJ. The pivotal role of hepatocytes in drug discovery. Drug Metabolism and Disposition 2007; 35: 859–865
   PubMed Web of Science ®Google Scholar
• Suzuki S, Sato T, Yoshino H, Kobayashi E. Impact of warm ischemia time on microsomal P450 isoforms in a porcine model of therapeutic liver resection. Life Science 2004; 76: 39–46
   PubMedGoogle Scholar
• Tang W, Stearns RA, Kwei GY, Iliff SA, Miller RR, Egan MA, Yu NX, Dean DC, Kumar S, Shou M, et al. Interaction of diclofenac and quinidine in monkeys: Stimulation of diclofenac metabolism. Journal of Pharmacology and Experimental Therapeutics 1999; 291: 1068–1074
   PubMed Web of Science ®Google Scholar
• Venkatakrishnan K, Von Moltke LL, Obach RS, Greenblatt DJ. Drug metabolism and drug interactions: Application and clinical value of in vitro models. Current Drug Metabolism 2003; 4: 423–459
   PubMed Web of Science ®Google Scholar
• Witherow LE, Houston JB. Sigmoidal kinetics of CYP3A substrates: An approach for scaling dextromethorphan metabolism in hepatic microsomes and isolated hepatocytes to predict in vivo clearance in rat. Journal of Pharmacology and Experimental Therapeutics 1999; 290: 58–65
   PubMed Web of Science ®Google Scholar